SCHEMBL1286424

SCHEMBL1286424

C=CCC(CCCCC)(CCCCCC/C=C\CCCCCCCC)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TERT O14746 3/20 0.49
PTPN1 P18031 3/20 0.49
PPARG P37231 3/20 0.49
PPARD Q03181 3/20 0.49
PPARA Q07869 3/20 0.49
TOP1 P11387 3/20 0.49
BLM P54132 3/20 0.49
HSD17B10 Q99714 3/20 0.49
MAPT P10636 2/20 0.49
FABP4 P15090 2/20 0.49
GMNN O75496 2/20 0.49
USP2 O75604 2/20 0.49
CYP1A2 P05177 2/20 0.49
POLB P06746 2/20 0.49
CYP2C9 P11712 2/20 0.49
APEX1 P27695 2/20 0.49
CYP2C19 P33261 2/20 0.49
RECQL P46063 2/20 0.49
DUSP3 P51452 2/20 0.49
PTPN7 P35236 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28966830 0.92 ZDHHC20 (0.42) PTPN1PPARGPPARDPPARAHSD17B10
SCHEMBL1703002 0.89 ZDHHC20 (0.42) PTPN1PPARGPPARDPPARAHSD17B10
SCHEMBL2143415 0.89 ZDHHC20 (0.42) PTPN1PPARGPPARDPPARAHSD17B10
SCHEMBL16414305 0.89 ZDHHC20 (0.42) PTPN1PPARGPPARDPPARAHSD17B10
SCHEMBL18154516 0.87 TERT (0.58) TERTPTPN1PPARGPPARDPPARA
SCHEMBL1626389 0.87 TERT (0.58) TERTPTPN1PPARGPPARDPPARA
SCHEMBL9955162 0.87 TERT (0.58) TERTPTPN1PPARGPPARDPPARA
SCHEMBL7522294 0.87 TERT (0.58) TERTPTPN1PPARGPPARDPPARA
SCHEMBL630533 0.87 TERT (0.58) TERTPTPN1PPARGPPARDPPARA
SCHEMBL31243003 0.87 TERT (0.58) TERTPTPN1PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2082014-B1 WATCH ROLEX SA (CH) 2018-02-14 EP disclosed
US-8951630-B2 Ultra-thin hydrophobic and oleophobic layer, method of manufacture and use in watchmaking as an epilame and in mechanical engineering as a barrier film ROLEX S.A. (CH) 2015-02-10 US disclosed
US-20120088099-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, METHOD OF MANUFACTURE AND USE IN WATCHMAKING AS AN EPILAME AND IN MECHANICAL ENGINEERING AS A BARRIER FILM SUSOS AG (CH) 2012-04-12 US disclosed
US-20100098926-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, ITS METHOD OF MANUFACTURE AND USE IN MECHANICS AS A BARRIER FILM SUSOS AG (CH) 2010-04-22 US disclosed
US-20100075138-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, METHOD OF MANUFACTURE AND USE IN WATCHMAKING AS AN EPILAME ROLEX S.A. (CH) 2010-03-25 US disclosed
US-20100068553-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, METHOD OF MANUFACTURE AND USE IN WATCHMAKING AS AN EPILAME ROLEX S.A. (CH) 2010-03-18 US disclosed
EP-2102319-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, ITS METHOD OF MANUFACTURE AND USE IN MECHANICS AS A BARRIER FILM SuSoS AG (CH) 2009-09-23 EP disclosed
EP-2084253-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, ITS METHOD OF MANUFACTURE AND USE IN CLOCKMAKING AS AN EPILAME ROLEX SA (CH) 2009-08-05 EP disclosed
EP-2084252-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, ITS METHOD OF MANUFACTURE AND USE IN CLOCKMAKING AS AN EPILAME Rolex S.A. (CH) 2009-08-05 EP disclosed
EP-2082014-A2 WATCH ROLEX SA (CH) 2009-07-29 EP disclosed
WO-2008064512-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, ITS METHOD OF MANUFACTURE AND USE IN MECHANICS AS A BARRIER FILM SUSOS AG (CH) 2008-06-05 WO disclosed
WO-2008064511-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, ITS METHOD OF MANUFACTURE AND USE IN CLOCKMAKING AS AN EPILAME ROLEX S.A. (CH) 2008-06-05 WO disclosed
WO-2008064510-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, ITS METHOD OF MANUFACTURE AND USE IN CLOCKMAKING AS AN EPILAME ROLEX S.A. (CH) 2008-06-05 WO disclosed
WO-2008064513-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, ITS METHOD OF MANUFACTURE AND USE IN MECHANICS AS A BARRIER FILM SUSOS AG (CH) 2008-06-05 WO disclosed
WO-2008052378-A2 TIMEPIECE ROLEX S.A. (CH) 2008-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075138-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, METHOD OF MANUFACTURE AND USE IN WATCHMAKING AS AN EPILAME KCNH3, HCN3, HCN4 TERT 3752/4885PTPN1 2904/4885PPARG 3517/4885
US-20100068553-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, METHOD OF MANUFACTURE AND USE IN WATCHMAKING AS AN EPILAME KCNH3, HCN3, HCN4 TERT 3608/4885PTPN1 2793/4885PPARG 3317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.